Skip to Content

NVR J 250 (Exjade 250 mg)

Generic Name: deferasirox

Pill with imprint NVR J 250 is White, Round and has been identified as Exjade 250 mg. It is supplied by Novartis Corporation.

Exjade is used in the treatment of thalassemia; iron overload; hemosiderosis and belongs to the drug class chelating agents. Risk cannot be ruled out during pregnancy. Exjade 250 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for NVR J 250

Exjade 250 mg NVR J 250
Exjade 250 mg NVR J 250
Exjade 250 mg NVR J 250

Exjade

Generic Name:
deferasirox
Imprint:
NVR J 250
Strength:
250 mg
Color:
White
Shape:
Round
Availability:
Prescription only
Drug Class:
Chelating agents
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Novartis Corporation
National Drug Code (NDC):
00078-0469

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide